Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03496610 · ClinicalTrials.gov registry record · Phase 4
Surgeon Infiltration QL Block Comparison
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT03496610 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 44 participants.
The verdict
NCT03496610, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if using a Quadratus Lumborum (QL) plane injection technique (also called a "nerve block") that numbs the nerves going to the abdominal area improve pain control after surgery compared to administration of local anesthetic directly to the surgical incision. The QL block technique uses a numbing solution (local anesthetics) that is injected next to nerves located along muscles in the back to reduce pain. This block will not affect movement in the leg and/or make the legs weak. Some institutions, including Duke, use the QL block for patients having various abdominal surgeries, with the hope of providing good pain relief combined with improved mobility after surgery.
Interventions
- PROCEDURE QL Block
- DRUG Liposomal Bupivicaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2023-02-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03496610
The ClinicalTrials.gov registry entry for NCT03496610 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which QL Block is the first listed.
NCT03496610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03496610 about?
NCT03496610 is a clinical study titled "Surgeon Infiltration QL Block Comparison". The purpose of this study is to learn if using a Quadratus Lumborum (QL) plane injection technique (also called a "nerve block") that numbs the nerves going to the abdominal area improve pain control after surgery compared to administration of local anesthetic directly to the surgical incision. The ...
What is the current status of trial NCT03496610?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2021-01-25. Estimated completion is 2023-02-23.
What interventions are being tested in trial NCT03496610?
The interventions under investigation include: QL Block (PROCEDURE), Liposomal Bupivicaine (DRUG).
Who is sponsoring clinical trial NCT03496610?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.